Abstract
BackgroundAndrogen deprivation therapy (ADT) is central in the management of advanced prostate cancer (PCa) but is associated with bone loss and occurrence of osteoporosis and fracture. Dual-energy x-ray absorptiometry (DXA)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
